PEREL POLITZER: Open Payments
NPI 1780380642 · NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 56 payments from 16 companies in 2025. Trend: 2023 $130 · 2024 $1,057 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 18 | $319 |
| Janssen Biotech, Inc. | 3 | $183 |
| ABBVIE INC. | 9 | $146 |
| Arcutis Biotherapeutics, Inc. | 4 | $76 |
| Lilly USA, LLC | 3 | $68 |
| Galderma Laboratories, L.P. | 3 | $67 |
| Amgen Inc. | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Botanix SB Inc | 2 | $36 |
Products named: OPZELURA, TREMFYA, SKYRIZI, Zoryve, OTEZLA, NEMLUVIO, Winlevi, TALTZ.
Industry payments across NY — which companies pay providers there.
